Status | Study |
Recruiting |
Study Name: Efficacy, Safety, Pharmacodynamic, and Pharmacokinetics Study of Olipudase Alfa in Patients With Acid Sphingomyelinase Deficiency Condition: Sphingomyelin Lipidosis Date: 2013-11-26 Interventions: Drug: placebo (saline) |
Withdrawn |
Study Name: Comparison of the Efficacy and Safety of AtorVastatin mOnotherapy vs. Combination Atorvastatin/Fenofibric Acid Condition: Mixed Hyperlipidemia Date: 2013-10-25 Interventions: Drug: Atorvastatin 10mg, fenofibric acid 135mg |
Completed |
Study Name: The Effect of Fibrate Therapy in Two Patients With Neutral Lipid Storage Disease With Myopathy (NLSDM) Condition: Neutral Lipid Storage Disease Date: 2012-01-16 Interventions: Drug: Fibrate treatment Patients will receive a dosage of 400mg Bezafibrate every day during 28 weeks |
Recruiting |
Study Name: Biomarker for Niemann Pick Type C Disease Condition: Niemann-Pick Disease Niemann-Pick Disease, Type C Date: 2011-03-01 |
Completed |
Study Name: Phase 2 Dose-Ranging Efficacy and Safety Trial of SCH 900271 in Participants With Primary Hypercholesterolemia or Mixed Hyperlipidemia (P05675) Condition: Primary Hypercholesterolemia Mixed Hyperlipidemia Date: 2009-07-16 Interventions: Drug: SCH 900271 15mg oral tab |
Completed |
Study Name: A Multicenter Study of the Efficacy of Cerezyme in Testing Skeletal Disease in Patients With Type I Gaucher Disease. Condition: Gaucher Disease Type I Cerebroside Lipidosis Syndrome Date: 2006-08-15 Interventions: Drug: Cerezyme (imiglucerase for injection) |
Completed |
Study Name: Safety and Efficacy of Cerezyme® Infusions Every 4 Weeks Versus Every 2 Weeks in Type 1 Gaucher Disease Condition: Gaucher Disease, Type 1 Cerebroside Lipidosis Syndrome Date: 2006-08-15 Interventions: Drug: Cerezyme Cerezyme doses of 20-60U/kg every 2 weeks (Q2 Arm) or 40-120 U/kg every 4 weeks (Q4 Arm). |
Completed |
Study Name: A Study of the Efficacy and Safety of Eliglustat Tartrate (Genz-112638) in Type 1 Gaucher Patients Condition: Gaucher Disease, Type 1 Cerebroside Lipidosis Syndrome Date: 2006-07-27 Interventions: Drug: Eliglustat tartrate Eliglustat (Genz-112638) capsule as single 50 mg dose on Day 1 then eliglustat |
Recruiting |
Study Name: International Collaborative Gaucher Group (ICGG) Gaucher Registry Condition: Gaucher Disease Cerebroside Lipidosis Syndrome Date: 2006-07-12 |
Completed |
Study Name: Lipid Efficacy and Safety in Participants With Mixed Hyperlipidemia (MK-0524B-024) Condition: Mixed Hyperlipidemia Date: 2006-02-07 Interventions: Drug: MK-0524A Drug: Atorvastatin |